Symbol: |
KAZALD1
|
Description: |
Kazal-type serine peptidase inhibitor domain 1 [Source:HGNC Symbol;Acc:25460]
|
Location: |
Chr10:102821598-102827888[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:230
Gene |
Compound |
Gen_sig |
Exp_pattern |
KAZALD1 |
C.I. 37559 |
0.017 |
Up |
KAZALD1 |
NSC 53454 |
0.01 |
Down |
KAZALD1 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.003 |
Up |
KAZALD1 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.026 |
Down |
KAZALD1 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.009 |
Down |
KAZALD1 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.006 |
Up |
KAZALD1 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.004 |
Up |
KAZALD1 |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.016 |
Down |
KAZALD1 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.013 |
Down |
KAZALD1 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.006 |
Up |
KAZALD1 |
NSC 651668 |
0.009 |
Up |
KAZALD1 |
(1R)-6-endo-Benzyloxycamphor |
0.008 |
Down |
KAZALD1 |
NSC 658288 |
0.039 |
Up |
KAZALD1 |
1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene |
0.001 |
Up |
KAZALD1 |
NSC 662119 |
0.047 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:12
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:66
Total:5 Current:1
[First] [Prev]  Next Last 
|